John E. Adent's most recent trade in Neogen Corp. was a trade of 2,112 Restricted Stock Units done . Disclosure was reported to the exchange on April 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neogen Corp. | John E. Adent | CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2025 | 2,112 | 4,224 | - | - | Restricted Stock Units | |
| Neogen Corp. | John E. Adent | CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.16 per share. | 28 Apr 2025 | 2,112 | 271,276 (0%) | 0% | 5.2 | 10,898 | Common Stock |
| Neogen Corp. | John E. Adent | CEO | Purchase of securities on an exchange or from another person at price $ 11.03 per share. | 16 Jan 2025 | 23,035 | 269,164 (0%) | 0% | 11.0 | 254,076 | Common Stock |
| Neogen Corp. | John E. Adent | CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2024 | 38,760 | 77,520 | - | - | Restricted Stock Units | |
| Neogen Corp. | John E. Adent | CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.81 per share. | 28 Oct 2024 | 38,760 | 257,409 (0%) | 0% | 13.8 | 535,276 | Common Stock |
| Neogen Corp. | John E. Adent | CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.81 per share. | 28 Oct 2024 | 11,280 | 246,129 (0%) | 0% | 13.8 | 155,777 | Common Stock |
| Neogen Corp. | John E. Adent | CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.43 per share. | 14 Oct 2024 | 3,064 | 219,541 (0%) | 0% | 14.4 | 44,214 | Common Stock |
| Neogen Corp. | John E. Adent | CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Oct 2024 | 3,064 | 6,127 | - | - | Restricted Stock Units | |
| Neogen Corp. | John E. Adent | CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.43 per share. | 14 Oct 2024 | 892 | 218,649 (0%) | 0% | 14.4 | 12,872 | Common Stock |
| Neogen Corp. | John E. Adent | CEO | Purchase of securities on an exchange or from another person at price $ 13.80 per share. | 11 Oct 2024 | 14,500 | 216,477 (0%) | 0% | 13.8 | 200,100 | Common Stock |
| Neogen Corp. | John E. Adent | CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2024 | 32,937 | 32,936 | - | - | Restricted Stock Units | |
| Neogen Corp. | John E. Adent | CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.07 per share. | 07 Oct 2024 | 32,937 | 211,563 (0%) | 0% | 15.1 | 496,361 | Common Stock |
| Neogen Corp. | John E. Adent | CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.07 per share. | 07 Oct 2024 | 9,586 | 201,977 (0%) | 0% | 15.1 | 144,461 | Common Stock |
| Neogen Corp. | John E. Adent | CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 784,636 | 2,129,279 | - | - | Common Stock (Right to Buy) | |
| Neogen Corp. | John E. Adent | CEO | Grant, award, or other acquisition of securities at price $ 16.79 per share. | 15 Aug 2024 | 107,207 | 483,514 (0%) | 0% | 16.8 | 1,800,006 | Common Stock |
| Neogen Corp. | John E. Adent | CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.96 per share. | 25 Apr 2024 | 2,113 | 171,979 (0%) | 0% | 12.0 | 25,271 | Common Stock |
| Neogen Corp. | John E. Adent | CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2024 | 2,113 | 6,338 | - | - | Restricted Stock Units | |
| Neogen Corp. | John E. Adent | CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.96 per share. | 25 Apr 2024 | 615 | 171,364 (0%) | 0% | 12.0 | 7,355 | Common Stock |
| Neogen Corp. | John E. Adent | CEO | 23 Apr 2024 | 17,899 | 170,288 (0%) | 0% | 11.8 | 211,369 | Common Stock | |
| Neogen Corp. | John E. Adent | CEO | 23 Apr 2024 | 17,477 | 169,866 (0%) | 0% | 12.1 | 211,297 | Common Stock | |
| Neogen Corp. | John E. Adent | CEO | Purchase of securities on an exchange or from another person at price $ 12.36 per share. | 10 Apr 2024 | 23,000 | 152,389 (0%) | 0% | 12.4 | 284,190 | Common Stock |
| Neogen Corp. | John E. Adent | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.67 per share. | 25 Apr 2023 | 656 | 81,907 (0%) | 0% | 16.7 | 10,936 | Common Stock |
| Neogen Corp. | John E. Adent | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2022 | 625,001 | 1,266,997 | - | - | Common Stock (Right to Buy) | |
| Neogen Corp. | John E. Adent | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2022 | 90,361 | 124,689 | - | - | Restricted Stock Units | |
| Neogen Corp. | John E. Adent | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 14.37 per share. | 28 Sep 2022 | 22,000 | 80,103 (0%) | 0% | 14.4 | 316,140 | Common Stock |
| Neogen Corp. | John E. Adent | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 23.07 per share. | 29 Jul 2022 | 17,500 | 58,103 (0%) | 0% | 23.1 | 403,725 | Common Stock |
| Neogen Corp. | John E. Adent | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2022 | 85,890 | 721,994 | - | - | Common Stock (Right to Buy) | |
| Neogen Corp. | John E. Adent | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2022 | 10,563 | 37,144 | - | - | Restricted Stock Units | |
| Neogen Corp. | John E. Adent | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Oct 2021 | 150,352 | 636,104 | - | - | Common Stock (Right to Buy) | |
| Neogen Corp. | John E. Adent | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Oct 2021 | 15,317 | 26,581 | - | - | Restricted Stock Units | |
| Neogen Corp. | John E. Adent | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 87.99 per share. | 31 Mar 2021 | 40,464 | 20,080 (0%) | 0% | 88.0 | 3,560,395 | Common Stock |
| Neogen Corp. | John E. Adent | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2021 | 25,826 | 257,514 | - | - | Common Stock (Right to Buy) | |
| Neogen Corp. | John E. Adent | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.70 per share. | 31 Mar 2021 | 25,826 | 45,906 (0%) | 0% | 62.7 | 1,619,290 | Common Stock |
| Neogen Corp. | John E. Adent | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.90 per share. | 31 Mar 2021 | 14,638 | 60,544 (0%) | 0% | 63.9 | 935,368 | Common Stock |
| Neogen Corp. | John E. Adent | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2021 | 14,638 | 242,876 | - | - | Common Stock (Right to Buy) | |
| Neogen Corp. | John E. Adent | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.70 per share. | 30 Mar 2021 | 9,536 | 29,616 (0%) | 0% | 62.7 | 597,907 | Common Stock |
| Neogen Corp. | John E. Adent | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2021 | 9,536 | 283,340 | - | - | Common Stock (Right to Buy) | |
| Neogen Corp. | John E. Adent | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 87.09 per share. | 30 Mar 2021 | 9,536 | 20,080 (0%) | 0% | 87.1 | 830,486 | Common Stock |
| Neogen Corp. | John E. Adent | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.18 per share. | 07 Jan 2021 | 20,000 | 16,080 (0%) | 0% | 84.2 | 1,683,694 | Common Stock |
| Neogen Corp. | John E. Adent | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2021 | 20,000 | 296,876 | - | - | Common Stock (Right to Buy) | |
| Neogen Corp. | John E. Adent | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.29 per share. | 07 Jan 2021 | 20,000 | 36,080 (0%) | 0% | 51.3 | 1,025,850 | Common Stock |
| Neogen Corp. | John E. Adent | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2020 | 76,877 | 316,876 | - | - | Common Stock (Right to Buy) | |
| Neogen Corp. | John E. Adent | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2020 | 7,040 | 7,040 | - | - | Restricted Stock Unit |